FDA Approves AstraZeneca’s Seroquel(R) for Maintenance Treatment in … - MSN MoneyCentral
WILMINGTON, Del., May 14 /PRNewswire-FirstCall/ — AstraZeneca AZN today announced that the U.S. Food and Drug Administration (FDA) has approved SEROQUEL(R) (quetiapine fumarate tablets) for the maintenance treatment of patients with bipolar I …